AC2993 (synthetic exendin-4) Patient Focus
PLUS Single
Insulin Injection
Type 2 Diabetes
Beta-cell function
Disease Progression
PLUS Multiple Insulin Injections
Diet Exercise
Normal
Absent
PLUS
Oral agents
CLINICAL STUDIES
Previous slide
Next slide
Back to first slide
View graphic version